# Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic Sclerosis

> **NCT03831438** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 9 (actual)

## Conditions studied

- Scleroderma, Diffuse

## Interventions

- **DRUG:** AVID200

## Key facts

- **NCT ID:** NCT03831438
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2020-06-20
- **Final completion:** 2020-06-20
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2024-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03831438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03831438, "Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic Sclerosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03831438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*